TrialHeart and vessels2020

Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.

Masayoshi Kiyokuni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.